WeightWatchers said Friday that its CEO Sima Sistani, who shifted the weight loss giant’s strategy to prescribing obesity ...
The biggest drug driving Sanofi’s and Regeneron’s businesses is about to get a bit bigger. On Friday, the FDA approved ...
Travere Therapeutics said there is a “voluntary pause” in recruitment to its Phase 3 study in a rare, inherited disorder due ...
Cassava Sciences and two of its former executives have reached a resolution with the SEC over charges for “misleading” ...
While the worst of the funding slump for digital health startups since the lofty highs of the pandemic seems to be drawing to ...
Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get ...
What makes a great biotech startup? Every year, the Endpoints 11 awards try to answer that question. We've spent the last ...
Lavigne Total raised More than $1 billion in committed capital Headquarters South San Francisco, CA David Baker’s Seattle ...
CEO Daphne Zohar Total raised $100 million Headquarters Boston, MA On Thursday, members of Seaport Therapeutics’ founding ...
The FDA on Thursday approved Bristol Myers Squibb’s new schizophrenia drug in one of the year’s most anticipated regulatory decisions. The approval gives Bristol Myers a significant foothold in the ...
The FDA lifted a clinical hold on two trials testing Biomea Fusion’s diabetes treatment. The news, announced Thursday, sent ...
AstraZeneca’s blockbuster lung cancer treatment Tagrisso scored a new FDA approval on Thursday in certain EGFR-mutated early-stage patients whose non-small cell lung cancer has not … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback